The Stanford medical school professor, the expected pick for the top job at the National Institutes of Health, has been a ...

New data suggests clinicians may be slower to recognize sepsis in people with pulmonary arterial hypertension.

Paul Fronstin, director of Health Benefits Research at EBRI, spoke with MHE about the challenges employers face in ...

Poor balance and coordination are prominent features of Friedreich’s ataxia (FRDA). Czech researchers found that neuropsychiatric symptoms are also common among patients with FRDA.

Imkeldi is a new formulation of imatinib approved as a strawberry-flavored, shelf-stable liquid designed to be more appealing ...

Whether this proposed rule actually has any impact remains to be seen, especially with a new administration led by Donald ...

Greg Baker, CEO of AffirmedRx, shared with MHE editors how the company is addressing ongoing challenges in the pharmacy ...

The menopause market is projected to increase at a CAGR of 5.10% between 2025 – 2033, with North America making up 4.9% ...

Attruby (acoramidis) is a small molecule approved to treat adults with transthyretin amyloid cardiomyopathy. It will have a ...

Marty Makary, M.D., M.P.H., as FDA administrator may be the least controversial of Trump's picks for the top healthcare jobs so far.

Seemal Desai, M.D., FAAD, discusses how treatment safety and effectiveness must be carefully evaluated through monitoring ...

CVS Caremark has removed several therapies to treat patients with diabetes in favor of newer products and generics, and is ...